Vascular Access Surveillance: Case Study of a False Paradigm

Seminars in Dialysis

Volumn 26, Issue 3, 2013, Pages 281-286

  Paulson, William D ^a   Moist, Louise ^b   Lok, Charmaine E ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; ARTICLE; GRAFT OCCLUSION; HEALTH SURVEY; HUMAN; KIDNEY DISEASE; PHYSIOLOGIC MONITORING; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; WORLD HEALTH ORGANIZATION;

ARTERIOVENOUS SHUNT, SURGICAL; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY DISEASES; MONITORING, PHYSIOLOGIC; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; WORLD HEALTH ORGANIZATION;

EID: 84878016007     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12049     Document Type: Article

References (36)

1. Kuhn TS: The Structure of Scientific Revolutions. 1st ed. Chicago, IL: University of Chicago Press, 1962: 1-172
2. Paulson WD, Moist L, Lok CE: Vascular access surveillance: an ongoing controversy. Kidney Int81:132-142, 2012
3. Paulson WD: Blood flow surveillance of hemodialysis grafts and the dysfunction hypothesis. Semin Dial14:175-180, 2001
4. KDOQI: Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis48:S176-S247, 2006
5. Besarab A, Sullivan KL, Ross RP, Moritz MJ: Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int47:1364-1373, 1995
6. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR: Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses. Kidney Int36:707-711, 1989
7. NKF-DOQI clinical practice guidelines for vascular access: National kidney foundation-dialysis outcomes quality initiative. Am J Kidney Dis30:S150-191, 1997
8. Allon M: Do we really need periodic monitoring of vascular access for hemodialysis?NephSap6:111-116, 2007
9. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB: Designing Clinical Research 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 2001
10. Lok CE, Moist LM: Challenges for randomized controlled trials in nephrology: illustrations in vascular access science and care. J Nephrol20:632-645, 2007
11. Gordis L: Epidemiology 2nd edn. W.B. Saunders: Philadelphia, 2000
12. Wilson JMG, Jungner G: Principles and practice of screening for disease. Public Health Paper Number 34, Geneva: World Health Organization, 1968: 7-39
13. White JJ, Ram SJ, Jones SA, Schwab SJ, Paulson WD: Influence of luminal diameters on flow surveillance of hemodialysis grafts: insights from a mathematical model. Clin J Am Soc Nephrol1:972-978, 2006
14. White JJ, Jones SA, Ram SJ, Schwab SJ, Paulson WD: Mathematical model demonstrates influence of luminal diameters on venous pressure surveillance. Clin J Am Soc Nephrol2:681-687, 2007
15. Paulson WD, Ram SJ, Work J, Conrad SA, Jones SA: Inflow stenosis obscures recognition of outflow stenosis by dialysis venous pressure: analysis by a mathematical model. Nephrol Dial Transplant23:3966-3971, 2008
16. DeSoto DJ, Ram SJ, Faiyaz R, Birk CG, Paulson WD: Hemodynamic reproducibility during blood flow measurements of hemodialysis synthetic grafts. Am J Kidney Dis37:790-796, 2001
17. Paulson WD, Ram SJ, Birk CG, Work J: Does blood flow accurately predict thrombosis or failure of hemodialysis synthetic grafts? A meta-analysisAm J Kidney Dis34:478-485, 1999
18. Dember LM, Holmberg EF, Kaufman JS: Value of static venous pressure for predicting arteriovenous graft thrombosis. Kidney Int61:1899-1904, 2002
19. McDougal G, Agarwal R: Clinical performance characteristics of hemodialysis graft monitoring. Kidney Int60:762-766, 2001
20. Paulson WD, Ram SJ, Birk CG, Zapczynski M, Martin SR, Work J: Accuracy of decrease in blood flow in predicting hemodialysis graft thrombosis. Am J Kidney Dis35:1089-1095, 2000
21. Ram SJ, Nassar R, Work J, Abreo K, Dossabhoy NR, Paulson WD: Risk of hemodialysis graft thrombosis: analysis of monthly flow surveillance. Am J Kidney Dis52:930-938, 2008
22. Chang CJ, Ko PJ, Hsu LA, et al.: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis43:74-84, 2004
23. Busk M, Mertz H, Espersen GT, Rasmussen K, Maeng M: Effects of pentoxifylline on the vascular response to injury after angioplasty in rabbit iliac arteries. Basic Res Cardiol103:257-264, 2008
24. Tonelli M, James M, Wiebe N, Jindal K, Hemmelgarn B: Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. Am J Kidney Dis51:630-640, 2008
25. Besarab A: Letter to "Is there a need to mandate access surveillance in the dialysis clinic?". Nephrol News Issues24:11-12, 2010
26. Zasuwa G, Frinak S, Besarab A, Peterson E, Yee J: Automated intravascular access pressure surveillance reduces thrombosis rates. Semin Dial23:527-535, 2010
27. Groopman J, Hartzband P: Why "quality" care is dangerous. The Wall Street Journal, April 8, 2009
28. Paulson WD, Work J: Controversial vascular access surveillance mandate. Semin Dial23:92-94, 2010
29. Abreo K, Allon M, Asif A, et al..: Which direction is right for vascular access surveillance? A debate. Nephrol News Issues24: 30-32, 2010, 34
30. American Society of Nephrology: ESRD Quality Incentive Program: ASN provides feedback on CMS proposals. Kidney News October/November:14-15, 2012
31. CMS Center for Medicaid and the State Operations/Survey and Certification Group: ESRD Interpretive Guidance Update. October 3, 2008
32. KDOQI: Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis47(Suppl 3):S33-53, 2006
33. FDA Drug Safety Communication: Modified dosing recommendations to improve the safe use of Erythropoiesis-Stimulating Agents (ESAs) in chronic kidney disease. http://www.fda.gov/Drugs/DrugSafety/ucm259639.htm. June 24, 2011
34. Manns BJ, Tonelli M: The new FDA labeling for ESA - Implications for patients and providers. Clin J Am Soc Nephrol7:348-353, 2012
35. Charytan C: Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs. Clin J Am Soc Nephrol5:2355-2362, 2010
36. US Renal Data System: ESRD Providers. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012: 324-325